<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1729-519X</journal-id>
<journal-title><![CDATA[Revista Habanera de Ciencias Médicas]]></journal-title>
<abbrev-journal-title><![CDATA[Rev haban cienc méd]]></abbrev-journal-title>
<issn>1729-519X</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Ciencias Médicas de la Habana]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1729-519X2018000300396</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Evolución de la Enfermedad Cerebrovascular Isquémica Aguda en pacientes con Síndrome Metabólico]]></article-title>
<article-title xml:lang="en"><![CDATA[Evolution of Acute Ischemic Cerebrovascular Disease in patients with Metabolic Syndrome]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Parada Barroso]]></surname>
<given-names><![CDATA[Yanneris]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hechavarría Córdoba]]></surname>
<given-names><![CDATA[Yaima]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mesa Barrera]]></surname>
<given-names><![CDATA[Yoany]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández Rodríguez]]></surname>
<given-names><![CDATA[Tania Elena]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Ciencias Médicas de La Habana Hospital Militar Central &#8220;Dr. Luis Díaz Soto&#8221; ]]></institution>
<addr-line><![CDATA[La Habana ]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Militar Central &#8220;Dr. Luis Díaz Soto&#8221;  ]]></institution>
<addr-line><![CDATA[La Habana ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2018</year>
</pub-date>
<volume>17</volume>
<numero>3</numero>
<fpage>396</fpage>
<lpage>407</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1729-519X2018000300396&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1729-519X2018000300396&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1729-519X2018000300396&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  La isquemia cerebral es la de mayor incidencia y prevalencia entre las enfermedades cerebrovasculares y con frecuencia se asocia a la presencia del síndrome metabólico, pues muchos de sus factores de riesgo conforman este síndrome.  Objetivo:  Determinar la relación entre la evolución del paciente con Enfermedad Cerebrovascular Isquémica aguda y la presencia de Síndrome Metabólico.  Material y Métodos:  Se realizó un estudio analítico prospectivo con una muestra de 100 pacientes. Se conformaron 2 grupos, uno con pacientes con Síndrome Metabólico(SM), según criterios del NCEP/ATPIII (III Panel de Tratamiento del Adulto del Programa Nacional de Educación en Colesterol) (grupo A), y otro sin Síndrome Metabólico (grupo B) .En ambos grupos se aplicó la escala de NIHSS para evaluar la severidad y evolución de la enfermedad cerebrovascular.  Resultados:  En el grupo con SM prevalecieron los del sexo masculino (60%), el color de piel blanca (52%) y la media de edad fue de 61,2 años. Los principales antecedentes patológicos personales fueron Hipertensión Arterial, Cardiopatías y Tabaquismo. La severidad de la enfermedad cerebrovascular al ingreso fue peor en el grupo A (media 13,2), los que tuvieron mayor número de complicaciones neurológicas: hipertensión endocraneana y convulsiones (12%), y no neurológicas: bronconeumonía (40%) y úlceras de decúbito (28%), con un riesgo superior: OR: 6,2. Al egreso, 36% de los pacientes con SM empeoraron, según escala de NIHSS.  Conclusiones:  El Síndrome metabólico constituye un factor que incrementa en la Enfermedad cerebrovascular isquémica el riesgo de complicaciones, y empeora su evolución y pronóstico.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction: Cerebrovascular ischemia represents the highest incidence and prevalence among cerebrovascular diseases. It is frequently associated with Metabolic Syndrome because many risk factors for cerebrovascular ischemia correspond to this entity.  Objective: To determine the relationship between the evolution of the patient with Acute Ischemic Cerebrovascular Disease (AICVD) and the presence of Metabolic Syndrome (MS).  Material and Methods:  An analytical prospective study was conducted with a sample of 100 patients, which were divided into two groups: group A, that was composed of patients with Metabolic Syndrome (MS) according to NCEP/ATPIII criteria (The Adult Treatment Panel III of the National Cholesterol Education), and group B that was composed of patients without Metabolic Syndrome. The National Institutes of Health Stroke Scale (NIHSS) was applied in both groups to evaluate the severity and evolution of cerebrovascular disease.  Results:  The Male sex (60%), and white people (52%) prevailed in the group with MS, and the mean age was 61,2 years. The main personal pathological antecedents were Arterial hypertension, cardiopathies, and smoking habit. The severity of cerebrovascular disease on admission was worse in group A (mean: 13,2). These patients presented a greater number of neurological complications such as: intracranial hypertension and convulsions (12%); they also presented non-neurological complications such as: bronchopneumonia (40%), and ulcers resulting from time spent on supine position (28%) with a higher risk (OR: 6,2). After discharge from hospital, 36% of patients with MS got worse, according to Scale NIHSS.  Conclusions:  The metabolic syndrome is a risk factor that increases the risk of complications in Ischemic Cerebrovascular Disease and worsens its evolution and prognosis.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Isquemia cerebral]]></kwd>
<kwd lng="es"><![CDATA[Síndrome Metabólico]]></kwd>
<kwd lng="es"><![CDATA[complicaciones]]></kwd>
<kwd lng="es"><![CDATA[evolución]]></kwd>
<kwd lng="es"><![CDATA[dislipidemia]]></kwd>
<kwd lng="es"><![CDATA[factores de riesgo]]></kwd>
<kwd lng="en"><![CDATA[cerebral ischemia]]></kwd>
<kwd lng="en"><![CDATA[metabolic syndrome (MS)]]></kwd>
<kwd lng="en"><![CDATA[complications]]></kwd>
<kwd lng="en"><![CDATA[evolution]]></kwd>
<kwd lng="en"><![CDATA[dyslipidemia]]></kwd>
<kwd lng="en"><![CDATA[risk factors]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Godoy]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Piñero]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz-Flores]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Alcalá Cerra]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Rabinstein]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Infarto hemisférico maligno de la arteria cerebral media. Consideraciones diagnósticas y opciones terapéuticas]]></article-title>
<source><![CDATA[Neurología]]></source>
<year>2016</year>
<month>.</month>
<volume>31</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>332-43</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lizarzaburu Robles]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome Metabólico: concepto y aplicación práctica]]></article-title>
<source><![CDATA[Anales. Fac. med]]></source>
<year>2013</year>
<month>.O</month>
<day>ct</day>
<volume>74</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vallejo Ramírez]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández-Brito Rodríguez]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Sera Blanco]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<source><![CDATA[Efecto de los Factores de Riesgo Aterogénicos en la Enfermedad Cerebrovascular. Convención Salud]]></source>
<year>2015</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[MINSAP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Buergo Zuaznábar]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández Concepción]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez Nellar]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lara Fernández]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Maya Entenza]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Pando Cabrera]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Guías de práctica clínica para las enfermedades cerebrovasculares]]></source>
<year>2009</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ekblom]]></surname>
<given-names><![CDATA[Ö]]></given-names>
</name>
<name>
<surname><![CDATA[Ekblom-Bak]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rosengren]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hallsten]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bergström]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Börjesson]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiorespiratory Fitness, Sedentary Behaviour and Physical Activity Are Independently Associated with the Metabolic Syndrome, Results from the SCAPIS Pilot Study]]></article-title>
<source><![CDATA[PLoSOne]]></source>
<year>2015</year>
<month>.</month>
<volume>13</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ancheta]]></surname>
<given-names><![CDATA[IB]]></given-names>
</name>
<name>
<surname><![CDATA[Tuason]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Levenson]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ancheta]]></surname>
<given-names><![CDATA[CV]]></given-names>
</name>
<name>
<surname><![CDATA[Battie]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Palaniappan]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[International Diabetes Federation (IDF), Harmonizing and National Cholesterol Education Program&#8217;s Adult Treatment Panel III (NCEP/ATP III) Definition for Metabolic Syndrome: Which of These Criteria Best Captures the Prevalence of Metabolic Syndrome Among Filipino Women?.]]></article-title>
<source><![CDATA[Global Heart]]></source>
<year>2014</year>
<volume>9</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Domínguez González]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Premio Póster Comité Científico: Inclusión de la Escala Neurológica del National Institute of Health (NIHSS) en la clínica de la Unidad de Ictus del Hospital del Mar]]></article-title>
<source><![CDATA[Rev Cient de la Sociedad Española de Enfer Neur]]></source>
<year>2009</year>
<volume>30</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>15-21</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<source><![CDATA[Escala NIHSS, National Institute of Health Stroke Score.]]></source>
<year>2017</year>
<publisher-loc><![CDATA[España ]]></publisher-loc>
<publisher-name><![CDATA[Grupo Neuro-Ictus. Sociedad Española de Medicina de Urgencias y Emergencias]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hadaegh]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Mohebi]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Cheraghi]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Tohidi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Moghaddam]]></surname>
<given-names><![CDATA[NB]]></given-names>
</name>
<name>
<surname><![CDATA[Bozorogmanesh]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Do Different Metabolic Syndrome Definitions Predict Cerebrovascular Events and Coronary Heart Disease Independent of Their Components? : 9 Years Follow-Up of the Tehran Lipid and Glucose Study]]></article-title>
<source><![CDATA[Stroke]]></source>
<year>2012</year>
<volume>43</volume>
<numero>6</numero>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mankowski]]></surname>
<given-names><![CDATA[RT]]></given-names>
</name>
<name>
<surname><![CDATA[Aubertin-Leheudre]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Beavers]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
<name>
<surname><![CDATA[Botoseneanu]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Buford]]></surname>
<given-names><![CDATA[TW]]></given-names>
</name>
<name>
<surname><![CDATA[Church]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[LIFE Research Group. Sedentary time is associated with the metabolic syndrome in older adults at high risk for mobility limitations - The LIFE Study]]></article-title>
<source><![CDATA[Exp Gerontol]]></source>
<year>2015</year>
<volume>70</volume>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Romano]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Salutto]]></surname>
<given-names><![CDATA[VL]]></given-names>
</name>
</person-group>
<source><![CDATA[Enfermedad cerebrovascular en pacientes muy ancianos: análisis prospectivo basado en un registro de población hospitalaria argentina]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arpa Gámez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[González Sotolongo]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Feliciano Álvarez]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Ferrer López]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Suárez Iznaga]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome metabólico como factor de riesgo en la enfermedad cerebrovascular]]></article-title>
<source><![CDATA[Rev Cub Med Milit]]></source>
<year>2005</year>
<volume>34</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Lim]]></surname>
<given-names><![CDATA[YH]]></given-names>
</name>
<name>
<surname><![CDATA[Shin]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Shin]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[KS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Impact of Metabolic Syndrome on Clinical Outcomes After Everolimus-Eluting Stent Implantation]]></article-title>
<source><![CDATA[Am J Cardiol]]></source>
<year>2015</year>
<volume>116</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[González Sotolongo]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Arpa Gámez]]></surname>
<given-names><![CDATA[Á]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández Sierra]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Influencia del Síndrome Metabólico sobre la evolución de pacientes hospitalizados en salas de Medicina Interna]]></article-title>
<source><![CDATA[Rev Cub Med Milit]]></source>
<year>2014</year>
<month>.</month>
<volume>43</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez Bonet]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Rivas Cartaza]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Vasallo Comendeiro]]></surname>
<given-names><![CDATA[VJ]]></given-names>
</name>
<name>
<surname><![CDATA[Ávalos Martín]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ponce Reines]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Complicaciones cardiovasculares perioperatorias en pacientes portadores de Síndrome Metabólico]]></article-title>
<source><![CDATA[Rev Cuba Anestesiol Reanim]]></source>
<year>2009</year>
<month>.D</month>
<day>ic</day>
<volume>8</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gimen Orna]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Lou Arnal]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Molinero Herguedas]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Boned Julián]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Portilla Córdoba]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Influencia del Síndrome Metabólico en el riesgo cardiovascular de pacientes con diabetes tipo 2]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2014</year>
<volume>57</volume>
<numero>6</numero>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Lv]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Pang]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Du]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[U-shaped relationships between sleep duration and metabolic syndrome and metabolic syndrome components in males: a prospective cohort study]]></article-title>
<source><![CDATA[Sleep Med]]></source>
<year>2015</year>
<month>.</month>
<volume>16</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>949-54</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
